Transcatheter Embolization and Occlusion Devices Market: Overview Analysis Report
Transcatheter Embolization and Occlusion Devices Market: Overview
According to Transparency Market Research’s latest report on the global transcatheter embolization and occlusion devices market for the historical period 2017–2018 and forecast period 2019–2027. Rise in prevalence of chronic diseases, technological advancements, increase in patient awareness and health care expenditure, and surge in need of treatment of complex diseases drive the global market during the forecast period.
According to the report, the global transcatheter embolization and occlusion devices market was valued at US$ 2,957.4 Mn in 2018 and is anticipated to expand at a CAGR of 7.8 % from 2019 to 2027. In terms of volume, the global transcatheter embolization devices were accounted at 73,92,954 units in 2018.
Request a Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2242
Increase in Spectrum of Transcatheter Embolization in Gynecologic and Obstetric Indications: Key Drivers
- Transcatheter embolization is a useful therapeutic option for a wide range of gynecologic and obstetric abnormalities. Transcatheter embolization procedures performed with the use of radiologic imaging for guidance are minimally invasive and could prevent surgery, thereby decreasing morbidity and mortality and conserving a patient’s future fertility potential.
- Under experienced interventional radiologists and essential technical support, transcatheter embolization can be performed for the treatment of numerous lesions in the female pelvis, including obstetric-gynecologic hemorrhage, advanced-stage malignancy, ectopic pregnancy, and arteriovenous malformation. It can also be used to treat pelvic congestion syndrome and symptomatic uterine fibroids in women who have undergone appropriate screening. Global success rate of 85% and higher have been reported in women treated with embolization for uterine fibroids.
Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=2242
Development of New Materials for Catheterization and Embolization Boost Market Growth
- As new materials for catheterization and embolization are developed, to provide greater vascular occlusion with regard to clinical performance and lower the complication rates. Many new agents have appeared on the market in the past several years.
- Liquid embolic agents under investigation are primarily targeted toward the treatment of aneurysms, AVMs, and HCC. The administration of currently available liquid embolic polymers, NBCA, Onyx, and PHIL are associated with the introduction of toxic compounds. Hence, several groups are investigating new in situ gelling polymer systems that avoid the use of toxic byproducts or solvents.
- The number of flow-directed embolic materials is expanding. The microspheres are prepared using a suspension polymerization process of poly(lactide-co-glycolide)-block-poly(ethylene glycol) crosslinker and PEGMA monomer. Co-monomers methacrylic acid (MA) and 2-methylene-1,3-dioxepane (MDO) were integrated to refine its properties.
Request Report Methodology: https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=2242
Post Embolization Syndrome to Hamper Market
- Embolization is a useful technique in the therapeutic management of patients with vascular injuries caused by trauma, liver surgery, or percutaneous procedures. Such injuries are unusual; however, the presence of hemobilia or hemoperitoneum resulting from pseudoaneurysm or laceration of a blood vessel could put a patient critically at risk. Selective embolization of the injury provides excellent results as far as hemostasis is concerned (86%), although an associated morbidity of 58% has been described, which is basically connected with bile leakage, liver abscesses, and/or necrosis. Such lesions should, therefore, be treated on an individual basis, with full awareness of the possible consequences of a technique that is not risk-free.
- The most common complication after embolization, the cause of which is still not properly understood, is the occurrence of fever, pain in the right hypochondrium, and a rise in transaminases. High temperature (< 38.5°C) may occur between 41% and 74% of cases and seems to be related to the presence of necrosis of the tumor and healthy tissue. Cytolysis (increase in transaminases), which has been observed in up to 93% of cases, is related to damage to healthy (noncancerous) hepatocytes.
Ask References: https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=2242
Global Transcatheter Embolization and Occlusion Devices Market: Competitive Landscape
- This report profiles major players in the global transcatheter embolization and occlusion devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
- The global transcatheter embolization and occlusion devices market is highly fragmented, with the presence of a number of international as well as regional players
- Leading players operating in the global transcatheter embolization and occlusion devices market are
- BTG plc
- Boston Scientific Corporation
- Medtronic plc
- Penumbra, Inc.
- Cook Medical
- Edwards Lifesciences Corporation
- Merit Medical Systems
- Johnson & Johnson Services, Inc.
- Pfizer, Inc.
- Stryker Corporation
- Terumo Corporation
- Sirtex Medical Limited
- Abbott Laboratories.
More Trending Reports by Transparency Market Research:
Meningitis Diagnostic Testing Market: https://www.transparencymarketresearch.com/emea-meningitis-diagnostic-testing-market.html
Heart Lung Machine Market: https://www.transparencymarketresearch.com/heart-lung-machine-market.html
ASEAN Biological Optical Microscope Market: https://www.transparencymarketresearch.com/asean-biological-optical-microscope-market.html
Gastrointestinal Testing Panels Market: https://www.transparencymarketresearch.com/emea-gastrointestinal-testing-panels-market.html
Assistive Technologies for Visually Impaired Market: https://www.transparencymarketresearch.com/assistive-technologies-visually-impaired-market.html
Vaginal Panel Testing Market: https://www.transparencymarketresearch.com/europe-middle-east-africa-vaginal-panel-testing-market.html
North America Lactate Meters Market: https://www.transparencymarketresearch.com/north-america-lactate-meters-market.html
Urinary Catheters Market: https://www.transparencymarketresearch.com/asia-pacific-urinary-catheters-market.html
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
